Ignite Creation Date:
2025-12-24 @ 5:32 PM
Ignite Modification Date:
2026-01-01 @ 2:01 PM
Study NCT ID:
NCT05309668
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-18
First Post:
2021-11-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to <7 Years With NF1-related Symptomatic, Inoperable PN
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-21
Start Date Type:
ACTUAL
Primary Completion Date:
2027-11-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-04-28
Completion Date Type:
ESTIMATED
First Submit Date:
2021-11-26
First Submit QC Date:
None
Study First Post Date:
2022-04-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-04-01
Results First Submit QC Date:
None
Results First Post Date:
2025-05-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-03
Last Update Post Date:
2025-12-18
Last Update Post Date Type:
ESTIMATED